Enhanced production of macrophage inhibitory protein-1α in patients with Behçet's disease

Scandinavian Journal of Rheumatology

Volumn 34, Issue 2, 2005, Pages 129-135

  Kim, W U ^a   Do, J H ^b   Park, K S ^b   Cho, M L ^b   Park, Sung Hwan ^b   Cho, C S ^b   Kim, H Y ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; INTERLEUKIN 8; IONOMYCIN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; RANTES; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 18844458605     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kaklamani VG, Variopoulus G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998;27:197-217.
2. Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity 1992;12:201-6.
3. Jorizzo JL, Solomon AR, Cavallo T. Behçet's syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 1985;109:747-51.
4. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol 1996;23:321-2.
5. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999;42:1967-74.
6. Alpsoy E, Cayirli C, Er H, Yilmaz E. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity. J Dermatol 1998;25:513-16.
7. Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002;31:205-10.
8. al-Dalaan A, al-Sedairy S, al-Balaa S, al-Janadi M, Elramahi K, Bahabri S, Siddiqui S. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995;22:904-7.
9. Kaburaki T, Fujino Y, Kawashima H, Merino G, Numaga J, Chen J, et al. Plasma and whole-blood chemokine levels in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 2003;241:353-8.
10. Baggiolini M. Chemokines in Behçet's disease, a field to be explored as a potential basis for therapy. Adv Exp Med Biol 2003;528:239-43.
11. Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 1989;3:2565-73.
12. Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 1988;167:1939-44.
13. Cook DN. The role of MIP-1α in inflammation and hematopoiesis. J Leukoc Biol 1996;59:61-6.
14. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002;13:455-81.
15. Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1 induces significant recruitment of neutrophils and monocytes. J Immunol 2000;164:3392-401.
16. DiPietro LA, Burdick M, Low QE, Kunkel SL, Stricter RM. MIP-1 as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998;101:16938.
17. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995;269:1583-5.
18. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, et al. Macrophage inflammatory protein-1α. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994;93:921-8.
19. Borzi RM, Mazzetti I, Macor S, Silvestri T, Bassi A, Cattini L, et al. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett 1999;455:238-42.
20. Weiss L, Si-Mohamed A, Giral P, Castiel P, Ledur A, Blondin C, et al. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1α and RANTES correlate with virus load in human immunodeficiency virus infection. J Infect Dis 1997;176:1621-4.
21. International Study Group for Behçet's Disease, Criteria for diagnosis for Behçet's disease. Lancet 1990;335:1078-80.
22. Cho CS, Cho ML, Chen PP, Min SY, Hwang SY, Park KS, et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 2002;168:4209-15.
23. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001;60:996-1002.
24. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
25. Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T. Monocyte activity in Behçet's disease. Br J Rheumatol 1996;35:424-9.
26. Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996;55:128-33.
27. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28-35.
28. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type 11 collagen-induced arthritis. J Clin Invest 1995;95:2868-76.
29. Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999;117:159-65.
30. Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1α, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2001;42:1547-52.
31. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-52.
32. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 2001;19:S19-24.
33. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, et al. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000;292:279-84.